List of Sirna Therapeutics patents

Patents where

Current Assignee

Name

Sirna Therapeutics

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7514099 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules	Patent 7514099 was granted and assigned to Sirna Therapeutics on April, 2009 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7514099	April 7, 2009
‌ US Patent 7641915 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules	Patent 7641915 was granted and assigned to Sirna Therapeutics on January, 2010 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7641915	January 5, 2010
‌ US Patent 7521184 Detection and quantitation of nucleic acid molecules in biological samples	Patent 7521184 was granted and assigned to Sirna Therapeutics on April, 2009 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7521184	April 21, 2009
‌ US Patent 7517864 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)	Patent 7517864 was granted and assigned to Sirna Therapeutics on April, 2009 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7517864	April 14, 2009
‌ US Patent 7858769 RNA interference mediated inhibition of gene expression using multifunctional short interfering nucleic acid (multifunctional siNA)	Patent 7858769 was granted and assigned to Sirna Therapeutics on December, 2010 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7858769	December 28, 2010
‌ US Patent 7923547 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)	Patent 7923547 was granted and assigned to Sirna Therapeutics on April, 2011 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7923547	April 12, 2011
‌ US Patent 7691405 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules	Patent 7691405 was granted and assigned to Sirna Therapeutics on April, 2010 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7691405	April 6, 2010
‌ US Patent 7491805 Conjugates and compositions for cellular delivery	Patent 7491805 was granted and assigned to Sirna Therapeutics on February, 2009 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7491805	February 17, 2009
‌ US Patent 7897752 RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)	Patent 7897752 was granted and assigned to Sirna Therapeutics on March, 2011 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7897752	March 1, 2011
‌ US Patent 7989612 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)	Patent 7989612 was granted and assigned to Sirna Therapeutics on August, 2011 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7989612	August 2, 2011
‌ US Patent 7956176 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)	Patent 7956176 was granted and assigned to Sirna Therapeutics on June, 2011 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7956176	June 7, 2011
‌ US Patent 8232383 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)	Patent 8232383 was granted and assigned to Sirna Therapeutics on July, 2012 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	8232383	July 31, 2012
‌ US Patent 7404969 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules	Patent 7404969 was granted and assigned to Sirna Therapeutics on July, 2008 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7404969	July 29, 2008
‌ US Patent 7858625 Conjugates and compositions for cellular delivery	Patent 7858625 was granted and assigned to Sirna Therapeutics on December, 2010 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7858625	December 28, 2010
‌ US Patent 8461313 Conjugates and compositions for cellular delivery	Patent 8461313 was granted and assigned to Sirna Therapeutics on June, 2013 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	8461313	June 11, 2013
‌ US Patent 8188247 Conjugates and compositions for cellular delivery	Patent 8188247 was granted and assigned to Sirna Therapeutics on May, 2012 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	8188247	May 29, 2012
‌ US Patent 7655790 Deprotection and purification of oligonucleotides and their derivatives	Patent 7655790 was granted and assigned to Sirna Therapeutics on February, 2010 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7655790	February 2, 2010
‌ US Patent 7777023 Method for the chemical synthesis of oligonucleotides	Patent 7777023 was granted and assigned to Sirna Therapeutics on August, 2010 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7777023	August 17, 2010
‌ US Patent 7893249 Deprotection and purification of oligonucleotides and their derivatives	Patent 7893249 was granted and assigned to Sirna Therapeutics on February, 2011 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7893249	February 22, 2011
‌ US Patent 7795422 RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)	Patent 7795422 was granted and assigned to Sirna Therapeutics on September, 2010 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7795422	September 14, 2010
‌ US Patent 7662951 RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)	Patent 7662951 was granted and assigned to Sirna Therapeutics on February, 2010 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7662951	February 16, 2010
‌ US Patent 7659390 RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)	Patent 7659390 was granted and assigned to Sirna Therapeutics on February, 2010 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7659390	February 9, 2010
‌ US Patent 7897753 RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA)	Patent 7897753 was granted and assigned to Sirna Therapeutics on March, 2011 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7897753	March 1, 2011
‌ US Patent 7910725 RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)	Patent 7910725 was granted and assigned to Sirna Therapeutics on March, 2011 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7910725	March 22, 2011
‌ US Patent 7683165 RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)	Patent 7683165 was granted and assigned to Sirna Therapeutics on March, 2010 by the United States Patent and Trademark Office.	Sirna Therapeutics	United States Patent and Trademark Office	7683165	March 23, 2010

Results per page:

41 results

0 selected

41 results

0 selected